Orbimed Advisors LLC Iveric Bio, Inc. Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $12.4 Million - $25.7 Million	1,361,400 New	1,361,400 $13.1 Million
Q4 2020 Feb 16, 2021	SELL	$5.65 - $7.66 $19.3 Million - $26.1 Million	-3,411,806 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $648,842 - $1.02 Million	161,806 Added 4.98%	3,411,806 $19.2 Million
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $7.65 Million - $16.5 Million	2,500,000 Added 333.33%	3,250,000 $16.6 Million
Q1 2020 May 15, 2020	SELL	$2.83 - $8.44 $707,500 - $2.11 Million	-250,000 Reduced 25.0%	750,000 $2.58 Million

Q4 2019 Feb 14, 2020	BUY	$0.93 - $8.58 $930,000 - $8.58 Million	1,000,000 New	1,000,000 $8.58 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.